The DEGS2 enzyme is differentially expressed in IDHmut gliomas [39], which accounts for the presence of phytoceramides that contribute to the sphingolipid rheostat imbalance observed in the IDHmut glioma subtypes [11]. This evidence concerns the gene DEGS2 and central nervous system cancer.